Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics

Abstract Recent studies show that rare, deleterious variants (RDVs) in certain genes are critical determinants of heritable cancer risk. To more comprehensively understand RDVs, we performed the largest-to-date germline variant calling analysis in a case-control setting for a multi-cancer associatio...

Full description

Bibliographic Details
Main Authors: Myvizhi Esai Selvan, Kenan Onel, Sacha Gnjatic, Robert J. Klein, Zeynep H. Gümüş
Format: Article
Language:English
Published: Nature Portfolio 2023-01-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-023-00354-3
_version_ 1797422839540744192
author Myvizhi Esai Selvan
Kenan Onel
Sacha Gnjatic
Robert J. Klein
Zeynep H. Gümüş
author_facet Myvizhi Esai Selvan
Kenan Onel
Sacha Gnjatic
Robert J. Klein
Zeynep H. Gümüş
author_sort Myvizhi Esai Selvan
collection DOAJ
description Abstract Recent studies show that rare, deleterious variants (RDVs) in certain genes are critical determinants of heritable cancer risk. To more comprehensively understand RDVs, we performed the largest-to-date germline variant calling analysis in a case-control setting for a multi-cancer association study from whole-exome sequencing data of 20,789 participants, split into discovery and validation cohorts. We confirm and extend known associations between cancer risk and germline RDVs in specific gene-sets, including DNA repair (OR = 1.50; p-value = 8.30e-07; 95% CI: 1.28–1.77), cancer predisposition (OR = 1.51; p-value = 4.58e-08; 95% CI: 1.30–1.75), and somatic cancer drivers (OR = 1.46; p-value = 4.04e-06; 95% CI: 1.24–1.72). Furthermore, personal RDV load in these gene-sets associated with increased risk, younger age of onset, increased M1 macrophages in tumor and, increased tumor mutational burden in specific cancers. Our findings can be used towards identifying high-risk individuals, who can then benefit from increased surveillance, earlier screening, and treatments that exploit their tumor characteristics, improving prognosis.
first_indexed 2024-03-09T07:38:11Z
format Article
id doaj.art-47e06faee0814247a1d715838f2deb86
institution Directory Open Access Journal
issn 2397-768X
language English
last_indexed 2024-03-09T07:38:11Z
publishDate 2023-01-01
publisher Nature Portfolio
record_format Article
series npj Precision Oncology
spelling doaj.art-47e06faee0814247a1d715838f2deb862023-12-03T05:27:04ZengNature Portfolionpj Precision Oncology2397-768X2023-01-017111210.1038/s41698-023-00354-3Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristicsMyvizhi Esai Selvan0Kenan Onel1Sacha Gnjatic2Robert J. Klein3Zeynep H. Gümüş4Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount SinaiDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount SinaiPrecision Immunology Institute, Icahn School of Medicine at Mount SinaiDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount SinaiDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount SinaiAbstract Recent studies show that rare, deleterious variants (RDVs) in certain genes are critical determinants of heritable cancer risk. To more comprehensively understand RDVs, we performed the largest-to-date germline variant calling analysis in a case-control setting for a multi-cancer association study from whole-exome sequencing data of 20,789 participants, split into discovery and validation cohorts. We confirm and extend known associations between cancer risk and germline RDVs in specific gene-sets, including DNA repair (OR = 1.50; p-value = 8.30e-07; 95% CI: 1.28–1.77), cancer predisposition (OR = 1.51; p-value = 4.58e-08; 95% CI: 1.30–1.75), and somatic cancer drivers (OR = 1.46; p-value = 4.04e-06; 95% CI: 1.24–1.72). Furthermore, personal RDV load in these gene-sets associated with increased risk, younger age of onset, increased M1 macrophages in tumor and, increased tumor mutational burden in specific cancers. Our findings can be used towards identifying high-risk individuals, who can then benefit from increased surveillance, earlier screening, and treatments that exploit their tumor characteristics, improving prognosis.https://doi.org/10.1038/s41698-023-00354-3
spellingShingle Myvizhi Esai Selvan
Kenan Onel
Sacha Gnjatic
Robert J. Klein
Zeynep H. Gümüş
Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics
npj Precision Oncology
title Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics
title_full Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics
title_fullStr Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics
title_full_unstemmed Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics
title_short Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics
title_sort germline rare deleterious variant load alters cancer risk age of onset and tumor characteristics
url https://doi.org/10.1038/s41698-023-00354-3
work_keys_str_mv AT myvizhiesaiselvan germlineraredeleteriousvariantloadalterscancerriskageofonsetandtumorcharacteristics
AT kenanonel germlineraredeleteriousvariantloadalterscancerriskageofonsetandtumorcharacteristics
AT sachagnjatic germlineraredeleteriousvariantloadalterscancerriskageofonsetandtumorcharacteristics
AT robertjklein germlineraredeleteriousvariantloadalterscancerriskageofonsetandtumorcharacteristics
AT zeynephgumus germlineraredeleteriousvariantloadalterscancerriskageofonsetandtumorcharacteristics